679 related articles for article (PubMed ID: 31148345)
61. Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition.
Huang MH; Chou YW; Li MH; Shih TE; Lin SZ; Chuang HM; Chiou TW; Su HL; Harn HJ
Pharmacol Res; 2019 Jan; 139():50-61. PubMed ID: 30385365
[TBL] [Abstract][Full Text] [Related]
62. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma.
Cong L; Bai Z; Du Y; Cheng Y
Biomed Res Int; 2020; 2020():9210891. PubMed ID: 32185224
[TBL] [Abstract][Full Text] [Related]
63. Shrimp miRNA suppresses the stemness of human cancer stem cells
Zhang S; Zhang X
FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761
[TBL] [Abstract][Full Text] [Related]
64. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
[TBL] [Abstract][Full Text] [Related]
65. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
66. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
[TBL] [Abstract][Full Text] [Related]
68. Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer.
Liang C; Rong Z; Tuerhong A; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Shi S; Xu J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834887
[TBL] [Abstract][Full Text] [Related]
69. ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer.
Yang J; Xu Y; Huo Y; Cai L; Hua R; Zhang J; Chen Z
J Immunol Res; 2021; 2021():5553425. PubMed ID: 33681386
[TBL] [Abstract][Full Text] [Related]
70. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
71. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
73. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
[TBL] [Abstract][Full Text] [Related]
74. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
[TBL] [Abstract][Full Text] [Related]
75. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
[TBL] [Abstract][Full Text] [Related]
76. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
[TBL] [Abstract][Full Text] [Related]
77. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion.
Yang J; Liu Y; Liu S
Cell Death Dis; 2023 Aug; 14(8):506. PubMed ID: 37550301
[TBL] [Abstract][Full Text] [Related]
78. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
79. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.
Li T; Ren T; Huang C; Li Y; Yang P; Che G; Luo L; Chen Y; Peng S; Lin Y; Zeng L
Biochem Pharmacol; 2021 Jul; 189():114396. PubMed ID: 33359364
[TBL] [Abstract][Full Text] [Related]
80. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer.
Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L
Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
